SCHEMBL6973405

SCHEMBL6973405

O=C(N[C@H]1CCN(C(=O)c2cc(-c3ccccc3)nc3ccccc23)C1)[C@@H]1CCCCN1c1nc2ccccc2o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.52
HCRTR2 O43614 1/20 0.52
TRPV1 Q8NER1 3/20 0.49
CYP2C9 P11712 5/20 0.47
LMNA P02545 3/20 0.47
ALDH1A1 P00352 2/20 0.47
TSHR P16473 2/20 0.47
USP30 Q70CQ3 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
MAPK1 P28482 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
MOK Q9UQ07 1/20 0.44
POLB P06746 1/20 0.44
HTT P42858 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6975651 0.91 RAB9A (0.47) HCRTR1HCRTR2TRPV1LMNAALDH1A1
SCHEMBL6975896 0.90 HCRTR1 (0.47) HCRTR1HCRTR2LMNATSHRSMN1; SMN2
SCHEMBL6979417 0.89 KDM4E (0.50) HCRTR1HCRTR2TRPV1CYP2C9LMNA
SCHEMBL6965850 0.82 HCRTR1 (0.50) HCRTR1HCRTR2LMNAALDH1A1TSHR
SCHEMBL6972771 0.81 SMN1; SMN2 (0.48) HCRTR1HCRTR2LMNAALDH1A1TSHR
SCHEMBL7680423 0.81 LMNA (0.58) HCRTR1HCRTR2LMNAALDH1A1TSHR
SCHEMBL6975687 0.77 LMNA (0.43) HCRTR1HCRTR2LMNATSHRSMN1; SMN2
SCHEMBL6968264 0.76 OPRK1 (0.56) LMNATSHRSMN1; SMN2HTTMAPT
SCHEMBL6978779 0.76 OPRK1 (0.56) LMNATSHRSMN1; SMN2HTTMAPT
SCHEMBL6966984 0.76 LMNA (0.50) HCRTR1HCRTR2CYP2C9LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP claimed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US claimed
US-6562964-B1 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders PFIZER INC 2003-05-13 US disclosed
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP disclosed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US disclosed